Your browser doesn't support javascript.
loading
Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA-Peptide Nanoparticles toward Treating Mesothelioma.
Anderson, Caleb F; Singh, Anand; Stephens, Tyler; Hoang, Chuong D; Schneider, Joel P.
  • Anderson CF; Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21701, USA.
  • Singh A; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Stephens T; Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 20701, USA.
  • Hoang CD; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Schneider JP; Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21701, USA.
Adv Mater ; 36(24): e2314367, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38532642
ABSTRACT
Broad size distributions and poor long-term colloidal stability of microRNA-carrying nanoparticles, especially those formed by polyelectrolyte complexation, represent major hurdles in realizing their clinical translation. Herein, peptide design is used alongside optimized flash nanocomplexation (FNC) to produce uniform peptide-based miRNA particles of exceptional stability that display anticancer activity against mesothelioma in vitro and in vivo. Modulating the content and display of lysine-based charge from small intrinsically disordered peptides used to complex miRNA proves essential in achieving stable colloids. FNC facilitates kinetic isolation of the mechanistic steps involved in particle formation to allow the preparation of particles of discrete size in a highly reproducible, scalable, and continuous manner, facilitating pre-clinical studies. To the best of the authors knowledge, this work represents the first example of employing FNC to prepare polyelectrolyte complexes of miRNA and peptide. Encapsulation of these particles into an injectable hydrogel matrix allows for their localized in vivo delivery by syringe. A one-time injection of a gel containing particles composed of miRNA-215-5p and the peptide PKM1 limits tumor progression in a xenograft model of mesothelioma.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / MicroARNs / Nanopartículas / Mesotelioma Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / MicroARNs / Nanopartículas / Mesotelioma Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article